GRANULOCYTE-COLONY-STIMULATING FACTOR IMPROVES HOST-DEFENSE TO RESUSCITATED SHOCK AND POLYMICROBIAL SEPSIS WITHOUT PROVOKING GENERALIZED NEUTROPHIL-MEDIATED DAMAGE
Jh. Patton et al., GRANULOCYTE-COLONY-STIMULATING FACTOR IMPROVES HOST-DEFENSE TO RESUSCITATED SHOCK AND POLYMICROBIAL SEPSIS WITHOUT PROVOKING GENERALIZED NEUTROPHIL-MEDIATED DAMAGE, The journal of trauma, injury, infection, and critical care, 44(5), 1998, pp. 750-759
Background: Granulocyte colony-stimulating factor (G-CSF) increases pr
oduction and release of neutrophil precursors and activates multiple f
unctions of circulating polymorphonuclear neutrophils (PMNs), G-CSF ha
s therapeutic effects in many experimental models of sepsis; its actio
ns with superimposed reperfusion insults are unknown. In traumatic con
ditions, G-CSF could exacerbate unregulated, PMN-dependent injury to o
therwise normal host tissue or, it could partially reverse trauma-indu
ced immune suppression, which may improve long-term outcome. This stud
y tested whether stimulating PMN proliferation and function with G-CSF
during recovery from trauma+sepsis potentiated reperfusion injury or
whether it improved host defense. Methods: Anesthetized swine were sub
jected to cecal ligation and incision, 35% hemorrhage, and 1 hr of hyp
otension. Resuscitation consisted of intravenous G-CSP (5 mu g/kg) or
placebo followed by shed blood and 40 mL/kg of lactated Ringer's solut
ion. The control group received laparotomy only. G-CSF or placebo was
given daily. Animals were killed at 4 days. Observers, blind to the pr
otocol, graded autopsy samples for localization of infection and quali
ty of abscess wall formation. Data included complete blood count, gran
ulocyte oxidative burst after phorbol myristate acetate stimulation in
vitro (GO(2)B), bronchoalveolar lavage (BAL) cell count, BAL noncellu
lar protein, lipopolysaccharide-stimulated tumor necrosis factor produ
ction in whole blood in vitro(lipopolysaccharide-tumor necrosis factor
), and lung tissue myeloperoxidase (MPO). Results: Neutrophilia and lo
calization of infection, were sig nificantly improved by G-CSF. Variab
les altered by G-CSF, though mot significantly, showed GO(2)B potentia
l increased by 50%, lipopolysaccharide-tumor necrosis factor decreased
by 50%, and improved survival versus placebo (100% vs. 70%). G-CSF di
d not increase lung MPO, BAL cell count, of BAL protein. Both arterial
and venous O-2 saturations were unaltered. Conclusions: Our data show
that G-CSF initiated at the time of resuscitation reduced the sequela
e of posttrauma sepsis by increasing PMN proliferation and function wi
thout potentiating PMN-mediated lung reperfusion injury.